NYSEMKT: PHGE
Biomx Inc Stock Ownership - Who owns Biomx?

Insider buying vs selling

Have Biomx Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James E. FlynnDirector2025-02-27353,249$0.93
$328.87kBuy
James E. FlynnDirector2025-02-27353,249$0.93
$328.87kBuy

1 of 1

PHGE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PHGE insiders and whales buy or sell their stock.

PHGE Shareholders

What type of owners hold Biomx Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Israel Biofund GP Limited Partnership902.22%13,773,653$78.65MInsider
Erez Chimovits303.08%4,626,978$26.42MInsider
Chidozie Ugwumba196.32%2,997,025$17.11MInsider
James E. Flynn163.37%2,494,108$14.24MInsider
Deerfield Management Company LP163.37%2,494,108$14.24MInstitution
Nantahala Capital Management LLC163.32%2,493,309$14.24MInstitution
Takeda Pharmaceutical Co Ltd161.85%2,470,935$14.11MInsider
Jonas Grossman136.26%2,080,217$11.88MInsider
Fibrosis Foundation Cystic117.10%1,787,758$10.21MInsider
Alyeska Investment Group LP104.20%1,590,738$9.08MInstitution

1 of 3

PHGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PHGE21.28%78.72%Net Buying
KPRX4.80%95.20%
CURX1.01%8.69%
BCTX0.28%99.72%
ALZN0.42%99.58%Net BuyingNet Selling

Biomx Stock Ownership FAQ

Who owns Biomx?

Biomx (NYSEMKT: PHGE) is owned by 550.58% institutional shareholders, 2,036.42% Biomx insiders, and 0.00% retail investors. Orbimed Israel Biofund GP Limited Partnership is the largest individual Biomx shareholder, owning 13.77M shares representing 902.22% of the company. Orbimed Israel Biofund GP Limited Partnership's Biomx shares are currently valued at $72.86M.

If you're new to stock investing, here's how to buy Biomx stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.